Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hürthle cell cytology

Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules

(2020) Masha J. Livhits et al.   JAMA Oncology

Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules

(2019) Trevor E. Angell et al.   THYROID

Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology

(2019) Yuri E. Nikiforov et al.   CANCER CYTOPATHOLOGY

Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms

(2019) Yangyang Hao et al.   BMC Systems Biology

Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules

(2018) Masha J Livhits et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules

(2018) Kepal N. Patel et al.   JAMA Surgery

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes

(2018) Ian Ganly et al.   CANCER CELL

Benign call rate and molecular test result distribution of ThyroSeq v3

(2018) N. Paul Ohori et al.   CANCER CYTOPATHOLOGY

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology

(2018) David L. Steward et al.   JAMA Oncology

The 2017 Bethesda System for Reporting Thyroid Cytopathology

(2017) Edmund S. Cibas et al.   THYROID

ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee

(2017) Franklin N. Tessler et al.   Journal of the American College of Radiology

A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules

(2016) Henry B. Burch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

(2016) Bryan R. Haugen et al.   THYROID

Hürthle cell carcinoma: current perspectives

(2016) Sara Ahmadi et al.   OncoTargets and Therapy

Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules

(2015) Eran Brauner et al.   THYROID

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay

(2014) Yuri E. Nikiforov et al.   CANCER

A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation

(2013) Edmund S. Cibas et al.   ANNALS OF INTERNAL MEDICINE

Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology

(2013) A. Yazgan et al.   CYTOPATHOLOGY

Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States

(2013) Julie Ann Sosa et al.   SURGERY

The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis

(2012) Massimo Bongiovanni et al.   ACTA CYTOLOGICA

Variability in the Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: Sources and Recommendations

(2011) N. Paul Ohori et al.   ACTA CYTOLOGICA